Skip to main content

Advertisement

Table 2 Hazard ratios (P wave ≥114 ms vs. P wave <114 ms) for total mortality, CVD and stroke mortality stratified by prevalent non-major macrovascular disease (PNMMVD)

From: Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease

  HR (95% CI)
  Age-adjusted hazard ratios Multivariate-adjusted hazard ratios
Variables P wave ≥114 vs. <114 ms P for interaction P wave ≥114 vs. <114 ms P for interaction
Total mortality     
No PNMMVD 0.75 (0.50-1.13)   0.70 (0.45-1.09)  
   0.020   0.047
PNMMVD 1.31 (1.03-1.66)*   1.18 (0.90-1.54)  
CVD mortality     
No PNMMVD 0.63 (0.36-1.10)   0.22 (0.27-0.90)*  
   0.010   0.015
PNMMVD 1.45 (1.09-1.93)*   1.32 (0.95-1.84)  
Stroke mortality     
No PNMMVD 0.47 (0.11-2.04)   0.36 (0.08-1.66)  
   0.057   0.089
PNMMVD 2.25 (1.18-4.31)*   2.45 (1.11-5.37)*  
  1. *P < 0.05 for the difference between P wave ≥114 vs. <114 ms. Variables in multivariate adjusted: age, sex, area of residence, diabetes duration, total cholesterol, HDL cholesterol, triglycerides(log), proteinuria(log), smoking, alcohol, HbA1, presence of hypertension, BMI, type of diabetes therapy, physical activity, heart rate and left ventricular hypertrophy.